GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 634 filers reported holding GLAXOSMITHKLINE PLC in Q2 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,380,635,000 | -30.7% | 108,030 | -31.0% | 0.72% | -35.3% |
| Q4 2015 | $6,320,835,000 | +6.1% | 156,650 | +1.1% | 1.11% | +3.2% |
| Q3 2015 | $5,959,677,000 | -34.8% | 154,998 | -29.3% | 1.07% | -31.5% |
| Q2 2015 | $9,135,827,000 | -3.4% | 219,348 | +7.0% | 1.57% | +34.6% |
| Q1 2015 | $9,459,636,000 | +24.4% | 204,976 | +15.2% | 1.16% | -17.3% |
| Q4 2014 | $7,606,803,000 | +9.7% | 177,979 | +18.0% | 1.41% | -0.7% |
| Q3 2014 | $6,931,159,000 | +4.3% | 150,776 | +21.3% | 1.42% | +10.2% |
| Q2 2014 | $6,646,954,000 | +17.8% | 124,289 | +17.6% | 1.29% | +5.0% |
| Q1 2014 | $5,644,552,000 | +17.8% | 105,644 | +17.7% | 1.23% | +16.2% |
| Q4 2013 | $4,791,700,000 | +19.9% | 89,749 | +12.7% | 1.06% | +10.2% |
| Q3 2013 | $3,995,108,000 | +15.5% | 79,631 | +15.1% | 0.96% | +2.7% |
| Q2 2013 | $3,457,495,000 | – | 69,191 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |